Status epilepticus (SE) is defined as a state of unrelenting seizure activity. It is associated with a rapidly rising mortality rate, and thus constitutes a medical emergency. Benzodiazepines, which act as positive modulators of chloride (Cl -) permeable GABAA receptors, are indicated as the first line of treatment, but this is ineffective in many cases. We found that 48% of children presenting with SE were unresponsive to benzodiazepine treatment, and critically, that the duration of SE at the time of treatment is an important predictor of non-responsiveness. We therefore investigated the cellular mechanisms that underlie acquired benzodiazepine resistance, using rodent organotypic brain slices. Removing Mg 2+ ions leads to an evolving pattern of epileptiform activity, and eventually to a persistent state of repetitive discharges that strongly resembles clinical EEG recordings of SE. We show that the persistent SE-like activity is associated with a reduction in GABAA receptor conductance and Cl -extrusion capability. We explored the effect on intraneuronal Cl -using both gramicidin, perforated-patch clamp recordings and Cl -imaging. This showed that during SE-like activity, reduced Cl -extrusion capacity was further exacerbated by activity-dependent Cl -loading, resulting in a persistently high intraneuronal Cl -. Consistent with these results, we found that optogenetic stimulation of GABAergic interneurons in the SE-like state, actually enhanced epileptiform activity in a GABAAR dependent manner. Together our findings describe a novel potential mechanism underlying benzodiazepine-resistant SE, with relevance to how this life-threatening condition should be managed in the clinic. 
Introduction
The great majority of all spontaneously occurring seizures terminate within a few seconds to minutes, and without medical intervention. When seizures fail to stop naturally, this is referred to as status epilepticus (SE). This represents a neurological emergency and requires immediate therapeutic intervention. SE occurs more frequently in children, and if not managed effectively, is associated with significant morbidity and even mortality (Boggs, 2004) . Current first-line treatment for SE recommends the use of benzodiazepines (Glauser et al., 2016) . These drugs work by positively modulating Cl --permeable ionotropic GABAA receptors (GABAAR), which underlie the majority of fast inhibitory neurotransmission within the brain. The intent is to boost inhibitory signalling in an attempt to terminate SE. Unfortunately, benzodiazepine treatment fails to terminate seizures in a large fraction of patients, which underscores the inadequacy of our current first-line therapeutic strategy for treating this condition (Appleton et al., 2000; Mayer et al., 2002; Chin et al., 2008) .
Current thinking in the field is that benzodiazepine resistance in SE is largely due to impaired GABAAR trafficking (Goodkin and Kapur, 2009 ). Both in vitro and in vivo animal models have shown that extended seizure activity is correlated with internalisation of GABAARs in the hippocampus (Kapur and Coulter, 1995; Goodkin et al., 2005; Naylor et al., 2005) . In addition, SE has been shown to be associated with a reduction in surface expression of GABAAR subunits (γ2), which are necessary for benzodiazepine binding (Goodkin et al., 2008) . This line of reasoning suggests that SE-induced changes to the GABAAR impairs the ability of benzodiazepines to enhance the GABAAR conductance, thereby resulting in treatment failure.
It is well accepted that the intracellular concentration of Cl -, and therefore the reversal potential for GABAARs (EGABA) can change over multiple time scales (Wright et al., 2011; Ellender et al., 2014; Sato et al., 2017) . Long-term changes in the expression of Cl -transporter proteins modifies steady-state EGABA over development and in multiple disease states including epilepsy (Moore et al., 2017) . In addition to these well-described long-term changes, short-term (seconds to minutes) changes in EGABA can occur following intense GABAA activation that causes Cl -influx, which can overwhelm Cl -extrusion mechanisms (Kaila et al., 1989; Staley et al., 1995; Wright et al., 2011) .
Furthermore, significant Cl -accumulation and a temporary excitatory shift in GABAergic signalling has been shown to accompany single seizure-like events in both in vitro (Lamsa and Kaila, 1997; Isomura et al., 2003; Fujiwara-Tsukamoto et al., 2010; Ilie et al., 2012; Ellender et al., 2014) and in vivo (Sato et al., 2017) models. The breakdown of the Cl -gradient serves to explain the surprising excitatory effects of GABAergic interneuronal subtypes recently observed during in vitro and in vivo seizure events (Ellender et al., 2014; Khoshkhoo et al., 2017; Magloire et al., 2018) . This suggests that in circuits where seizures have caused sufficient Cl -loading, GABAAR mediated synaptic signalling can serve to exacerbate rather than control hyperexcitablity, which has direct relevance for the inhibitory efficacy of benzodiazepines. Deeb et al. (2013) have previously demonstrated that the benzodiazepine diazepam has reduced inhibitory capability under these conditions of activity-driven Cl -accumulation. However, it is currently unknown as to whether Cl -dynamics and seizure-associated shifts in GABAergic signalling are involved in the development of benzodiazepine resistance in SE.
In this study we combine clinical and experimental data to explore the phenomenon of benzodiazepine-resistant SE. First we document the incidence of benzodiazepine resistance in a South African cohort of paediatric patients in SE and provide the first clinical evidence that seizure 6 duration prior to treatment is a valuable predictor of benzodiazepine resistance. As SE is most often caused by acute brain insults resulting in sustained seizure-activity, we used the acute in vitro 0 Mg 2+ model of SE (Dreier et al., 1998) to explore the cellular mechanisms underlying acquired benzodiazepine resistance. We demonstrate that the benzodiazepine diazepam loses its anticonvulsant efficacy and can actually enhance epileptiform discharges during SE-like activity.
Utilising gramicidin perforated patch-clamp recordings, Cl -imaging and optogenetic control of GABAergic interneurons, we characterise changes in intracellular Cl -and GABAergic signalling during the development of SE. We find that although GABA mediated conductances are reduced in early SE, diazepam resistance is associated with deficits in Cl -extrusion capability and profound activity-dependent Cl -accumulation which results in excitatory interneuronal signalling via
GABAARs.
Materials and methods

Clinical data
Clinical data was obtained from paediatric patients presenting with convulsive status epilepticus (CSE) to the Red Cross War Memorial Children's Hospital (RCWMCH) from 2015 to 2018 as part of a clinical trial. This study was approved by the University of Cape Town Human Ethics
Commiittee (HREC 297/2005) and the protocol was registered on the ClinicalTrials.gov registry (NCT03650270). CSE was defined as any seizure that lasts longer than five minutes, or multiple discrete seizures between which there is no extended period of recovery between events (Trinka et al., 2015) . Upon admission, all patients were treated with benzodiazepines. If CSE continued after two doses of benzodiazepines, patients were then given second-line therapy. Study data was collected using REDCap (UCT eResearch Centre).
Organotypic hippocampal brain slice preparation
Slices were prepared from GAD2-cre-tdTomato mice (C57BL/6 background, JAX lab) or wistar rats. The GAD2-cre-tdTomato strain which resulted in cre-recombinase and tdTomato expression in all GABAergic interneurons (Taniguchi et al., 2011) . The use of animals was approved by either the University of Cape Town (mouse) or the University of Oxford (rat) animal ethics committees. Organotypic brain slices were prepared using 7 day old animals and followed the protocol originally described by (Stoppini et al., 1991) (for details see Raimondo et al. (2016) ).
For experiments using optogenetics, after 1 day in culture, slices prepared from GAD2-cretdTomato mice were transduced with adeno-associated vector serotype 1 (AAV1) containing a floxed-STOP channelrhodopsin (ChR2) linked to a yellow fluorescent protein (YFP), which resulted in selective expression of ChR2 in GABAergic interneurons (Royo et al., 2008) . For Cl -imaging experiments, neurons were biolistically transduced with ChlopHensorN construct following the same procedure described by Raimondo et al. (2013) . Recordings were performed 2-7 days post-transfection.
Electrophysiology
Brain slices were transferred to a submerged recording chamber (whole-cell and perforated patch experiments) or an interface recording chamber (LFP experiments) where they were continuously superfused with standard artificial CSF (aCSF) bubbled with carbogen gas (95% O2: 5% CO2) using peristaltic pumps (Watson-Marlow). The standard aCSF was composed of (in mM): NaCl (120); KCl (3); MgCl2 (2); CaCl2 (2); NaH2PO4 (1.2); NaHCO3 (23); D-Glucose (11) with pH adjusted to be between 7.35-7.40 using 0.1 mM NaOH. For patch-clamp experiments, neurons were visualized using a BX51WI upright microscope (Olympus) using 20x or 40x waterimmersion objectives, and targeted for recording. For whole-cell recordings, micropipettes were prepared from borosilicate glass capillaries (Warner Instruments) and filled a low Cl -internal solution composed of (in mM): Kgluconate (120); KCl (10); Na2ATP (4); NaGTP (0.3); Na2-phosphocreatinine (10) and HEPES (10).When recording GABAergic synaptic currents, pipettes were filled with a high Cl -internal solution (Cl -141mM) composed of (in mM): KCl (135), NaCl (8.9) and HEPES (10). Gramicidin perforated recordings (Kyrozis and Reichling, 1995) were performed using glass pipettes containing the high Cl -internal solution. Adequate perforation of the membrane was assessed by monitoring access resistance and was defined when access resistance was <90 MΩ. Patch-clamp recordings were made with Axopatch 200B amplifiers (Molecular Devices) and data acquired using WinWCP (University of Strathclyde). LFP recordings were performed using an AC-coupled amplifier (AM Systems). Data was acquired using the LabChart Pro (AD Instruments) with recordings processed using a 140Hz low-pass filter.
SLEs were defined as events where significant deviations from the resting potential in LFP and patch-clamp recordings (>2 standard deviations) lasting at least 5 seconds. The LRD phase was defined as recurrent epileptiform discharges that persisted for at least 5 minutes. Slices that developed spontaneous SLEs prior to 0 Mg 2+ exposure were excluded from analysis in order to ensure that prior epileptiform activity would not have altered the neuronal network (Kamphuis et al., 1991; Morimoto et al., 2004) . The following drugs were used: diazepam; flumazenil; CGP-35348; kynurenic acid; tetrodotoxin or QX-314 (all from Tocris Bioscience).
Confocal imaging
A confocal microscope (Zeiss) was used to visualise tdTomato and YFP-labelled ChR2 expression using 561 nm and 488 nm lasers. ClopHensorN (modified from the original ClopHensor by Arosio et al. (2010) ) expressing neurons were excited using 458, 488 and 561 nm lasers and emission collected by photomultiplier tubes (PMTs): between 500 -550 nm for EGFP and 635 -700 nm for the tdTomato. Calibration of the reporter and Cl -measurements were made as previously described Raimondo et al. (2013) .
Cell surface biotinylation and western blotting
Organotypic hippocampal slices were incubated for 3 hours at 28°C-30°C, in either control aCSF or aCSF with 0 Mg 2+ , while continuously bubbling with 95% O2-5% CO2. Biotinylation was performed to produce "total" and "surface" protein lysate samples as described in (Wright et al., 2017) . Blots were incubated with rabbit anti-C-terminus KCC2 (1:500, Merck Millipore) followed by horseradish peroxidise (HRP)-conjugated goat anti-rabbit antibody (1:2000, Thermo Scientific). For each sample, the surface protein was normalized against the total protein, which was run in the adjacent lane. As the ratio of surface/total was calculated within each sample, this controlled for differences in overall protein levels across samples and variance associated with loading.
Data analysis
Clinical data was analysed using SPSS Statistics (IBM) while experimental data analysis was performed using Matlab (MathWorks). Statistical measurements were performed using GraphPad Prism. Data reported as mean ± SEM unless otherwise stated.
Data availability statement
Upon publication, all data presented in this manuscript will be made available on an open-access data repository. Fig. 1D ).
Results
Benzodiazepine
The median duration of SE prior to the time of initial treatment was 50.0min (interquartile range 36.5min), but notably, longer SE durations were increasingly associated with benzodiazepine resistance (bzpR SE duration = 40.0 ± 24.0min (median ± interquartile range); bzpS SE duration = 65.00 ± 50.00min; p < 0.0001, Mann-Whitney U test, Fig. 1E ). These data suggested that the duration of SE at the time of admission could be a useful clinical classifier, especially since benzodiazepine resistance is associated with enhanced morbidity. We addressed this question using receiver operating characteristic (ROC) curve analysis ( Fig. 1F) , by assessing the relative proportions of true positive rates (short duration SE are bzpS; long duration SE are bzpR) to false positive rates, as the classifier time changes from short (top right) to long (bottom left) durations.
The area under curve (AUC) of 0.75 indicates that SE duration does indeed discriminate between these two patient populations, and importantly, it further indicates that the optimum discrimination threshold occurs at almost exactly 1 hour (maximal deviation from the diagonal was at 61 min;
Fig. 1E,F).
A contingency table ("confusion matrix") using 1 hour as the cut off (see Supplementary Table 1 ), shows that prior to this time, 67% of patients responded to benzodiazepine, but after that, only 18% did.
These clinical data suggest strongly that a critical factor is the continued seizure activity itself, and that the benzodiazepine resistance is an acquired, activity-dependent phenotype. There are striking parallels of pharmacoresistance, acquired over a similar time course, in acute rodent in vitro models, and so we used such a model to explore the underlying cellular mechanism.
Early application of diazepam is anticonvulsant whilst late application enhances epileptiform activity in an in vitro model of status epilepticus
Our clinical data demonstrated a diverse set of causes for SE, and no particular set of causes of SE which enhanced the likelihood of benzodiazepine resistance. As acute brain insults (the most common cause in our clinical cohort) causing extended seizures lasting minutes to hours can result in benzodiazepine resistance, we used the well characterised in vitro 0 Mg 2+ model of acute seizures and SE (Anderson et al., 1986; Mody et al., 1987; Gutiérrez and Heinemann, 1999; Albus et al., 2008) . Here Mg 2+ removal from the artificial cerebrospinal fluid (aCSF), results in initial interictal-like activity followed by the gradual development of seizure-like events, which mimic what is observed in temporal lobe seizures in humans (Anderson et al., 1986; Dreier et al., 1998) .
Importantly, after extended periods of Mg 2+ withdrawal, distinct ictal events no longer occur and are replaced by persistent seizure-like activity in the form of recurrent epileptiform discharges (Anderson et al., 1986; Dreier et al., 1998) , which strongly resemble clinical EEG recordings of SE ( Fig. 2A,B) . This late-stage activity is also referred to as the late recurrent discharge phase (LRD) and represents the best available in vitro model of SE (Zhang et al., 1995; Dreier et al., 1998) . We therefore sought to determine the effect of diazepam on the evolution of in vitro seizure-like activity using mouse organotypic hippocampal brain slices maintained on interface in the 0 Mg 2+ model of SE. 
t-test). These findings confirm that
GABAergic signalling in the organotypic slices are sensitive to diazepam during baseline activity.
We then monitored the evolution of 0 Mg 2+ induced seizure activity using local field potential recordings with slices on interface, whilst diazepam (3µM) was either applied 'early', i.e. together with the proconvulsant 0 Mg 2+ solution, or 'late' once epileptiform activity had already entered the SE-like late recurrent discharge (LRD) phase. Early application of diazepam significantly delayed onset of SLEs compared to the control and late groups, which were not exposed to diazepam prior to onset of SLEs (early: 799.73s ± 89.81s, n = 13 vs control: 522.15 ± 45.93s, n = 10 and late: 548.8 ± 34.46s, n = 9, p = 0.003 and p = 0.008, Mann-Whitney test, Fig. 2C-F In contrast, we found that diazepam lost its anticonvulsant effect once epileptiform activity had become persistent (SE-like activity) and increased some markers of epileptiform activity. To quantify this effect we analysed the properties of burst discharges within a predefined 60s window 7 mins after the onset of the LRD phase. We found a significant increase in discharge duration 
Persistent epileptiform activity is associated with a reduction in GABAergic synaptic conductances
Having observed that diazepam lost its anticonvulsant efficacy and enhanced burst discharges during LRD, we next sought to determine whether synaptic GABAAR internalisation (Goodkin et al., 2005) and hence a reduction in GABA synaptic conductance (gGABA) could underlie this effect.
We optogenetically activated GABAergic neurons, and recorded postsynaptic GABA-R mediated currents, in voltage-clamp mode, in CA1 pyramidal neurons in mouse organotypic slice cultures.
( Fig. 3A) . By recording GABA currents at different holding voltages gGABA could be measured before and after 30 mins exposure to 0 Mg 2+ in the same neuron. GABAB receptor blockade to isolate GABAARs was not utilised as this could interfere with the seizure-like activity evoked by 0 Mg 2+ (Swartzwelder et al., 1987; Codadu et al., 2018) . Following termination of SE-like activity using reintroduction of Mg 2+ , gGABA was remeasured. The mean gGABA elicited under baseline conditions decreased from 23.63 ± 4.10 nS to 13.07 ± 3.17 nS, after SE-like activity had been
, with no significant change in access resistance (15.68 ± 1.03MΩ vs 18.60 ± 1.18MΩ, p =0.11, paired t-test). These findings demonstrate that SE-like activity is associated with reductions in GABA synaptic conductances which is most likely caused by GABAAR internalisation (Goodkin et al., 2005) . Nonetheless, despite prolonged periods of persistent seizure-like activity in vitro, optogenetic activation of GABAergic interneurons could still reliably evoke GABA synaptic currents.
Status epilepticus-like activity is accompanied by compromised neuronal Cl -extrusion
We surmised that additional mechanisms to GABAAR internalisation must also play a role in the loss of diazepam's anticonvulsant efficacy during LRD. This is because GABAAR internalisation Fig. 4B-D) . We further investigated this effect in rat hippocampal organotypic slices, extending the period of 0 Mg 2+ withdrawal and putative SE-like activity to 3 hours. This also resulted in increases in EGABA from -80.84 ± 2.78 mV to -68.63 ± 3.52 mV, n = 7, p = 0.04, Mann-Whitney test (Fig. 4E) .
We next used surface biotinylation and western blotting for the major cation-chloride cotransporter (KCC2) to determine whether the depolarizing shift in EGABA was accompanied by a shift in the cell surface expression of KCC2. Indeed, on average, the total amount of surface KCC2 in organotypic hippocampal slices treated with 0 Mg 2+ was reduced to 76.4 ± 0.05% of that found in control slices (n = 9, p = 0.003, unpaired t-test, Fig. 4F,G) . When KCC2 was further subdivided into monomeric and dimeric forms it was found that this drop in surface protein was almost exclusively due to a reduction in the KCC2 dimer. Zero Mg 2+ treatment reduced the levels of surface bound KCC2 dimer to 60.6 ± 8.8% of controls (p = 0.002, unpaired t-test, n =9). In contrast, monomeric KCC2 showed little difference across the two conditions with the mean in the 0 Mg 2+ condition at 97.0 ± 6.7% that of control (p = 0.66, unpaired t-test). These findings confirm previous reports (Rivera et al., 2004) that prolonged seizure activity results in a reduction in expression of KCC2 and a depolarizing shift in steady-state EGABA.
Persistent epileptiform activity drives pronounced depolarizing shifts in EGABA and intracellular Cl -accumulation
The shifts in steady-state EGABA we observed above are unlikely to explain the enhancing effect of diazepam on burst discharges we observed during SE-like activity. This is because resting EGABA ' s of ~ -60 mV are typically below the action potential (AP) threshold from of CA1 neurons in our preparation (AP threshold: -38.72 ± 5.45mV, n = 17) and thus would still render GABAAR mediated transmission inhibitory. We therefore surmised that compromised Cl -extrusion combined with the activity-dependent Cl -loading during SE-like activity could result in more severe shifts in EGABA.
To explore this possibility, we modified our gramicidin perforated patch-clamp recording protocols in order to track dynamic changes in EGABA during the evolution of epileptiform activity in the 0 Mg 2+ model (Fig. 5A) . The recording configuration was rapidly switched between currentclamp mode in order to measure membrane potential and short periods in voltage-clamp mode, during which a voltage ramp protocol and somatic GABA puff was applied, to provide a rapid estimate of EGABA (Fig. 5B) . Compared to baseline, SLEs were associated with pronounced increases in EGABA. EGABA shifted from mean baseline levels of -83.88 ± 1.13 mV to -42.71 ± 1.04 mV during SLEs (n = 7, p < 0.0001, paired t-test) before partially recovering to a mean level of -78.92 ± 1.13 mV between events (Fig. 5C,D (Fig. 6A) .
We noticed that GABAergic interneurons were highly active during the LRD phase (Fig6. C,D) .
To determine whether the activity of GABAergic interneurons was synchronised with that of pyramidal cells we used linear correlation as a measure of synchrony (Jiruska et al., 2013) . We 
GABAergic signalling is strongly depolarising during the late recurrent discharge phase
Given our observations of a depolarizing EGABA and highly synchronized GABAergic interneuronal and pyramidal cell activity during the SE-like activity of the LRD phase, we next explored whether the GABAergic signalling might in fact be excitatory during LRD. To investigate this, we used an optogenetic approach to isolate and selectively activate ChR2-expressing GABAergic (GAD2+) interneurons during different phases of seizure-like activity.
Using this experimental setup, GABAergic interneurons were activated every 7s with 100ms of blue light whilst performing whole-cell current-clamp recordings from CA1 pyramidal neurons during the progression of seizure-like activity in the 0 Mg 2+ model.
We observed that whilst light activation resulted in hyperpolarizing synaptic potentials under baseline conditions, (Fig. 7A-C) , during single SLEs, light delivery reliably triggered membrane depolarisation and the generation of action potentials (Fig. 7B,C) . In-between SLEs, the hyperpolarising responses to optogenetic activation were restored. However, during the SE-like LRD phase, light activation again consistently resulted in strong depolarisation and action potentials in the recorded neurons (Fig. 7C) .
We then repeated this with cells held at -40 mV in the voltage-clamp configuration in order to record light-induced synaptic currents. At rest these were outward (positive), with a mean value of 448.80 ± 70.34 pA (n = 7) but rapidly flipped to being inward (negative) during SLEs (-752 ± 88.67 pA, p = 0.0002, paired t-test, Fig. 7D-F Our data suggests that the GABAergic inhibitory system becomes ineffective during SE-like activity due to changes in chloride homeostasis and this could explain the failure of diazepam to reduce seizure-like activity during this phase. To further test this hypothesis, we next sought to determine whether recruitment of GABAergic interneurons fails to inhibit epileptiform activity during LRD and furthermore, whether selective activation of interneurons results in more proseizure like effects than anti-seizure activity as was witnessed following diazepam application in our preparation.
During a one minute analysis period during the LRD phase, we analysed our traces in 7 s frame windows to determine what effect selective activation of GABAergic interneurons (100 ms blue light activation occurring 3.5 s into the 7 s window) had on epileptiform activity. This 7 s window was then divided into smaller 200 ms time bins whereby the probability of an epileptiform discharge being initiated could be calculated (Fig. 8A-D) . Discharges were defined as inward currents greater than 10 standard deviations from baseline noise and lasting more than 500 ms.
We observed that the probability of discharge initiation increased to 0.78 ± 0.06 during the 200 ms immediately following light application. In a control experiment (n = 7) repetitive light activation was initiated after a minimum of five minutes of LRD activity had occurred. The probability of discharge initiation within the 200 ms time bin 3.5 s into the 7 window increased from 0.06 ± 0.02 before the light pulses were delivered to 0.53 ± 0.09 when the light was delivered at the start of this time bin (p =0.002, paired t-test, Fig. 8E-I ).
Having established that optogenetic activation of GABAergic interneurons reliably initiated epileptiform discharges during SE-like activity, we next sought to determine whether excitatory GABAAR synaptic signalling was responsible for this effect. To do so we added the GABAAR blocker picrotoxin (100 µM) to the perfusing aCSF after at least 5 minutes of LRD activity had been induced (Fig. 8J -N) . The picrotoxin did not arrest the LRD activity demonstrating that GABAAR mediated synaptic transmission is not necessary for the generation of these discharges (n = 6). However, we did note that the probability of discharge initiation following optogenetic activation of GABAergic interneurons decreased significantly from 0.64 ± 0.08 to 0.08 ± 0.03 following GABAAR blockade with picrotoxin (p = 0.03, Wilcoxon test, Fig. 8J -N) . This confirmed that GABAAR mediated transmission is necessary for the pro-seizure properties of the GABAergic interneuronal network during LRD.
Finally, we measured changes in the frequency of epileptiform discharges during LRD when GABAergic interneurons were optogenetically activated at 0.14 Hz ('On'), when the light was not applied ('Off') and when optogenetic activation occurred in the presence of 100 µM pictrotoxin ('Px'). As demonstrated in Fig. 8O and P, in the 'On' condition, the frequency of discharges was entrained either to the frequency of light delivery (0.14 Hz) or twice the frequency (0.28Hz), indicating one 'break through' discharge every cycle. By comparison, if there was no light activation or picrotoxin was present, there was a wide distribution of discharge frequencies. In addition, there was a significantly smaller difference between the frequency at which the light was delivered and the frequency of discharges between the `On' group (0.06 ± 0.02 Hz) as compared to the `Off' (0.12 ± 0.03 Hz, p =0.03, Mann-Whitney test) and picrotoxin groups (0.13 ± 0.02 Hz, p = 0.02, Mann-Whitney test, Fig. 8Q ). Taken together this data demonstrates that GABAergic interneurons are ineffective at curtailing epileptiform discharges during SE-like activity and can enhance epileptiform activity.
Discussion
In our study we have used both clinical and experimental data to explore the phenomenon of benzodiazepine-resistant SE. We find that the prevalence of benzodiazepine resistance in a South
African cohort of paediatric patients in SE is similar to that observed internationally (Chin et al., 2008) . In addition, our clinical data also confirms several prior observations, that actually provide some critical insights into the underlying pathology and clinical management. Firstly, benzodiazepine resistant SE is associated with increased morbidity in patients (Chin et al., 2008) .
Secondly, the proportion of patients who responded patients who seize for longer prior to initial treatment were more likely to be resistant to benzodiazepine treatment. While previous studies and reviews have eluded to longer SE duration being associated with increased resistance to benzodiazepines (Deeb et al., 2012; Naylor, 2014; Fernández et al., 2015) , our clinical data is the first to quantify this phenomenon. Notably, we show that the duration of SE can successfully be used as a binary classifier to detect benzodiazepine resistance in SE. In our patient population, the optimum threshold for discriminating between benzodiazepine resistant vs sensitive patients was 61 mins of seizure activity.
Given the clinical importance of this phenomenon, and our observation that diverse brain insults causing prolonged seizures can all result in benzodiazepine resistance, we used the 0 Mg 2+ in vitro model of SE to identify multiple changes in GABAergic signalling that could explain the progressive loss of diazepam efficacy in this condition. SE-like activity was accompanied by a modest reduction in GABA synaptic conductance and persistent changes in the efficacy of Cl -extrusion. However, our major observation was profound short-term, activity-dependent Cl -accumulation during SE-like activity. As a result, optogenetic activation of GABAergic interneurons was ineffective at reducing epileptiform activity; on the contrary, GABAergic interneuron firing actually enhanced epileptiform discharges during SE, via excitatory GABAAR mediated synaptic transmission. This activity-dependent effect is supplemental to two other changes we document, namely the reduced KCC2 expression, and the associated shift in baseline EGABA. Together, these results demonstrate why benzodiazepines may fail to enhance inhibition in continuously seizing brain circuits.
The withdrawal of Mg 2+ in vitro has long been used as a model for studying putative changes in GABAergic signalling during SE (Dreier and Heinemann, 1991; Goodkin et al., 2005; Albus et al., 2008) . Dreier et al. (1998) were the first to demonstrate that benzodiazepines lose their anticonvulsant efficacy following the onset of the SE-like LRD phase in the 0 Mg 2+ model. We extend this work by demonstrating that during SE-like activity, not only do benzodiazepines lose their anticonvulsant action, but further, they can even exacerbate seizure-like activity. We suggest that the effects of diazepam during SE we observe are not explained by previously described deficits in GABAAR trafficking on principal cells alone (Goodkin et al., 2008) , but also by a transient collapse in the transmembrane Cl -gradient and EGABA.
Previous reports suggest that on-going seizure activity results in reduced surface expression, and function, of the canonical Cl -extruder KCC2 (Rivera et al., 2004) . KCC2 ensures that Cl -is maintained at levels lower than would be predicted by passive processes and also ameliorates activity-dependent Cl -loading (Düsterwald et al., 2018) . Loss of KCC2, therefore, constitutes a double blow to the system, since it will cause a rise in baseline intraneuronal [Cl -] , and reduce the rate of clearance of Cl -, meaning that activity-dependent Cl -loading is exacerbated. We have shown both effects are important. Our findings confirm that the progression to SE-like activity in the 0 Mg 2+ model is accompanied by a reduction in KCC2 surface expression and function as evidenced by a progressive depolarization of resting EGABA prior to and following SE-like activity.
We then also showed the additional importance of short-term, activity-dependent, increases in Cl -. These have previously been demonstrated during single SLEs both in vitro and in vivo (Isomura et al., 2003; Ellender et al., 2014; Sato et al., 2017) , but our new data represents the first time this has been shown to be a factor in persistent SE-like activity. Our gramicidin perforated patchclamp recordings and Cl -imaging measurements using the genetically encoded ratiometric reporter ClopHensorN demonstrate that both single SLEs and SE-like activity result in substantial intracellular Cl -accumulation and an excitatory shift in EGABA. In support of this idea, reducing the function of KCC2 accelerates the transition to SE both in vitro (Kelley et al., 2016) and in vivo (Silayeva et al., 2015) .
Seizures are able to start and spread due to a loss of inhibitory synaptic mechanisms which are typically recruited to "restrain" excitability within brain circuits (Trevelyan et al., 2006; Trevelyan et al., 2007; Trevelyan and Schevon, 2013) . Ongoing failure of inhibitory restraint also underlies the ability of seizures to perpetuate in time and space. Inhibitory restraint can fail due to reduced GABA release (Zhang et al., 2012) , GABAAR internalization (Goodkin et al., 2005) , a depolarizing shift in pyramidal EGABA (Lillis et al., 2012) or GABAergic interneurons entering a state of depolarization block (Ziburkus et al., 2006; Cammarota et al., 2013) . Knowing which of these mechanisms are involved in SE, and to what extent, will be important for designing optimal strategies for aborting seizures, especially given recent interest in using optogenetic strategies to enhance the action of GABAergic interneurons (Krook-Magnuson et al., 2013; Krook-Magnuson and Soltesz, 2015) . Using dual whole-cell patch-clamp recordings, we found a very high correlation between hippocampal GABAergic interneuronal and pyramidal cell activity during the LRD phase. Optogenetic activation of the pan-interneuronal population using ChR2 expression driven by the GAD2 promoter revealed that activation of GABAergic interneurons has a broadly similar effect on epileptiform activity as diazepam in our model. Interneurons are inhibitory prior to SLEs and excitatory during SE-like activity. We found that optical activation of the paninterneuronal population was sufficient to entrain the frequency of epileptiform discharges to the frequency of light activation during the SE-like phase, and that this entrainment is dependent on intact synaptic transmission via GABAARs. This provides strong evidence about three key aspects of interneuronal function during the early phase of SE: that GABAergic interneurons are able to release GABA, they are not in depolarizing block, and sufficient postsynaptic GABAARs are present to mediate GABAergic synaptic transmission. However, due to the transient and widespread collapse of the postsynaptic Cl -gradient in pyramidal neurons, GABAergic interneurons are ineffective at curtailing epileptiform discharges, and in fact drive the generation of these events during SE-like activity. Our data complements recent in vitro and in vivo results, which suggest that various GABAergic interneuronal subtypes may promote the extension of seizures when activated once epileptiform activity has become established (Ellender et al., 2014; Sato et al., 2017; Magloire et al., 2018) .
Our observation of excitatory GABAAR mediated signaling during the LRD phase explains the loss of inhibitory efficacy and the pro-epileptiform effects of diazepam we observe during the LRD phase. This supports prior work in dissociated cell cultures which demonstrated that activitydriven changes in the Cl -gradient reduce the inhibitory efficacy of diazepam (Deeb et al., 2013) .
Together, this suggests that benzodiazepines can lose their efficacy in SE even with GABAARs intact.
Given our experimental findings, it is worth considering why benzodiazepines are often effective in terminating SE in patients (in our study 52% of patients with SE responded to benzodiazepine administration). Organotypic hippocampal brain slices represent a relatively small, well connected brain circuit, where most areas of the slice are typically involved in SE-like activity (Ellender et al., 2014) . This means that most pyramidal cells in the slice will experience an activity-dependent collapse of the Cl -gradient, which will render benzodiazepines ineffective during prolonged seizures. In patients with SE, the situation is likely to be different. The proportion of brain circuits effected by activity-dependent Cl -accumulation will vary considerably between patients depending on the seizure type as well as the extent to which different brain areas are recruited into the seizure process. Interactions between areas may also be critical in providing pacemaker drives (Codadu et al., 2018) , thereby maintaining a high rate of discharge, but breaking this loop by slightly reducing the intrinsic rate at a particular site may be all that is required. In regions where intracellular Cl -and EGABA are still low, benzodiazepines will enhance inhibitory restraint.
Therefore, determining the potential cumulative effect of benzodiazepines will involve a dynamic contest between areas where it enhances inhibition and those areas where it is ineffective or promotes hyperexcitability.
Given the demonstrated potential for benzodiazepines to be ineffective, or even promote seizure prolongation in SE, we recommend investigation of alternative or adjunctive therapeutic strategies for terminating SE. These could involve strategies for enhancing Cl -extrusion capacity to help maintain EGABA (Gagnon et al., 2013; Alfonsa et al., 2016; Moore et al., 2017; Magloire et al., 27 2018), or targeting of other brain inhibitory systems including modulating pH (Tolner et al., 2011) , postsynaptic K + conductance or presynaptic release (Ilie et al., 2012) . For example, co-application of flurpitine (which opens M-type potassium channels) with diazepam is highly effective in terminating SE in animal models (Zhang et al., 2017) . Finally, since the degree of Cl -loading is dictated by the relative rates of entry and clearance, it may be possible to restore benzodiazepine efficacy by slowing the rate of discharges. This, after all, is what appears to occur typically in seizures which self-terminate.
In summary, our findings support the idea that dynamic network changes and ionic mechanisms underlie persistent seizure activity and that an enhanced understanding of these alterations will guide the development of more effective strategies for treating SE. and the LRD phase (t4). 'GAD2', glutamic acid decarboxylase 2; 'ns', non-significant; 'SR', stratum radiatum; 'Td', tandem dimeric tomato. ****p £ 0.0001; 'ns', not significant (p ³ 0.05). 
